While Novo is struggling to keep up with demand for its obesity drugs, U.S. rival Eli Lilly sees supply restraints easing.
What Sanders didn’t realize was that Denmark, a country of 6 million, was enduring its own crisis over how to pay for the Novo Nordisk drugs Ozempic and Wegovy. Most other developed countries ...
For many years, Denmark’s Novo Nordisk was the pharmaceutical company that could do no wrong by shareholders – under the 16-year tenure of chief executive Lars Sørensen, it achieved an ...
Cambridge, USA-based Korro Bio has entered a collaboration with Denmark’s Novo Nordisk to advance the discovery and ...
On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 ...
Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives. The vision of the Foundation is to improve people's health and the ...
NBC News' Meagan Fitzgerald sits down with Novo Nordisk CEO Lars Jorgenson in Denmark to discuss the high costs and limited supply of the company's popular weight loss drugs, Ozempic and Wegovy ...
As tradition has it, Novo Nordisk holds its summer party at Roskilde Dyrskueplads, the same spot where Roskilde Festival is held.“All employees who work in Denmark are invited, which is more ...
Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a ...
The firms will collaborate on two lead programs and up to five future targets in other diseases, with NanoVation eligible for up to $600 million in payments from Novo Nordisk.
Denmark is updating the wage levels used to assess work permit applications from October 1st, meaning most applicants will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback